Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing vaccine production worldwide
3.2.1.2 Increasing prevalence of cancer across globe
3.2.1.3 Technological innovation in cell line development
3.2.1.4 Growing biotechnology industry
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complex regulatory landscape
3.2.2.2 Issues related to stem cell research
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Products & Services, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Reagents & media
5.3 Equipment
5.3.1 Incubator
5.3.2 Centrifuges
5.3.3 Bioreactors
5.3.4 Storage equipment
5.3.5 Microscopes
5.3.6 Electroporators
5.3.7 Fluorescence-activated cell sorting
5.3.8 Other equipment
5.4 Accessories & consumables
5.5 Services
Chapter 6 Market Estimates and Forecast, By Source, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Mammalian
6.3 Non-mammalian
6.3.1 Insects
6.3.2 Amphibians
Chapter 7 Market Estimates and Forecast, By Cell Line, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Recombinant
7.3 Hybridomas
7.4 Continuous cell lines
7.5 Primary cell lines
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Bioproduction
8.3 Drug discovery
8.4 Toxicity testing
8.5 Tissue engineering
8.6 Research applications
Chapter 9 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical & biotechnology companies
9.3 Academic & research institutes
9.4 Contract research organizations (CROs)
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Advanced Instruments, LLC
11.2 Aragen Life Sciences Ltd.
11.3 ASIMOV
11.4 Cytiva (Danaher Corporation)
11.5 Eurofins Scientific
11.6 Fyonibio
11.7 GenScript Biotech
11.8 Lonza Group AG
11.9 Novartis AG
11.10 ProBioGen
11.11 PromoCell
11.12 Sartorius AG
11.13 Sigma Aldrich (Merck KGaA)
11.14 Thermo Fisher Scientific Inc.
11.15 WuXi AppTec
